Biotech China 2014

View Profile


Grant Support

Start year End year Title Source Position
1. 2009 2011 Optimal Predictors of Response to Trastuzumab NIH P.I
2. 2006 2011 Yale SPORE in Skin Cancer NA Co Investigator
3. 2008 2010 Development of a protein based tests to determine which patients with early stage non-small cell lung cancer are cured by surgery alone STATE OF CT P.I
4. 2008 2010 Novel methods to localize protein-protein interactions in fixed cells and tissues NIH Co Investigator
5. 2005 2010 Predicting Metastasis to Lymph Nodes (in breast cancer) NIH P.I
6. 2009 Intrinsic Controls for FFPE tissue NIH P.I
7. 2009 In situ detection of Cancer Stem Cells to Predict Non-Nodal Metastasis in Breast Cancer Susan G. Komen Foundation P.I
8. 2006 2009 Predicting Metastasis in Melanoma NIH P.I
9. 2005 2009 Predicting response to BAY43-9006 and chemotherapy in melanoma NIH P.I
10. 2004 2008 Molecular Classifications of Response to Therapy in HER2 Positive, Early Stage Breast Cance DOD Co Investigator
11. 2004 2008 Prediction of Breast Cancer Response to Hormonal Therapy NIH P.I
12. 2007 Transformation by the NEU Oncogene Product & EGF NIH Co Investigator
13. 2005 2007 Qualitative Analysis of Tissue Biomarkers and Pathways NIH Co Investigator
14. 2005 2007 Multiplex Analysis of In Situ Protein Expression to Predict Response to Herceptinâ„¢ Avon-NCI Progress for Patients P.I
15. 2005 2006 : Spectral-Spatial Imaging to Detect Pre-malignancy Greenwich Breast Cancer Alliance P.I
16. 2003 2006 Quantitative in situ Assessment of the Somatostatin Receptor in Breast Cancer to Assess Response to Targeted Therapy with 111-In-pentetriotide US Army Co Investigator
17. 2003 2005 Contract for Automated Analysis of Prostate Tissue Microarrays Harvard Prostate Spore Program P.I
18. 2003 2005 A New Quantitative in situ Proteomic Assay NIH P.I
19. 2002 2005 Spectral Analysis of Breast Cancer on Tissue Microarrays: Seeing Beyond Morphology US Army Breast Cancer Research Program P.I
20. 2003 2004 Contract for Evaluation Automated Analysis of Tissue Microarrays Pfizer, Inc P.I
21. 2002 2004 Breast Cancer Tissue Microarray Resource for Polish Women’s Health Study NIH NCI P.I
22. 2001 2004 Outcome based screening for Prognostic Phospho-RTK antibodies using Tissue Microarrays US Army Breast Cancer Research Program P.I
23. 2001 2004 Supplement Spectral Illumination, Genetic Algorithms And Tissue Arrays NIH Co Investigator
24. 2003 New Technology for Measuring Absolute Protein Concentrations Within Subcellular Compartments Greenwich Breast Cancer Alliance P.I
25. 2001 2003 Lymphoma Tissue Microarray Studies Ted Mann Lymphoma Foundation P.I
26. 2001 2003 High Throughput Analyses of Markers in the Progression of Normal Melanocytes to Melanomas NIH Co Investigator
27. 1999 2003 Adhesion-based mechanisms for prediction of cancer metastasis Donaghue P.I
28. 1998 2003 The Establishment and Regulation of Cell-cell Adhesion NIH P.I
29. 2001 2002 Contract for Evaluation of Antibodies Using Tissue Microarrays Cell Signaling Technologies, Inc P.I
30. 1999 2001 Molecular Clonality Assay for Early Cancer Diagnosis NIH P.I
31. 1999 2001 The value of Met for prediction of metastasis in breast cancer NIH P.I
32. 1999 2001 QBCytology, a novel mechanism for detection of circulating cancer cells NIH P.I
33. 1995 1998 The Role of Catenins in Cell-cell Adhesion and Metastasis Donaghue Medical Research Foundation P.I
34. 1994 1997 Alterations in Cell Adhesion Molecules in Breast Cancer Army Breast Cancer Research Program P.I
35. 1996 Investigations for Automated Diagnosis in Urinary Cytology Neuromedical and Neurosciences Center Consultant
36. 1994 1995 Mutation in the ras Oncogene as a Molecular Diagnostic Tool for Evaluation of Pancreatic Adenocarcinoma Mather Foundation Critical Technologies P.I


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.